Increase Mirtazapine Dose to 15-30 mg Daily
Given only partial improvement on mirtazapine 7.5 mg daily, you should increase the dose to 15-30 mg daily, as 7.5 mg is below the therapeutic range and a full therapeutic trial requires adequate dosing for 6-8 weeks. 1, 2
Rationale for Dose Escalation
Your current dose of 7.5 mg is subtherapeutic. Guidelines consistently specify that:
- Starting dose: 7.5-15 mg at bedtime 1
- Therapeutic range: 15-45 mg daily 1
- Maximum dose: 30-45 mg at bedtime 1
The FDA label confirms mirtazapine was studied at doses of 15-45 mg/day (mean effective doses 21-32 mg/day), demonstrating superiority over placebo at these therapeutic doses 3.
Evidence-Based Dosing Strategy
Increase by 7.5-15 mg increments every 5-7 days until you reach 15-30 mg daily 1. Research specifically addressing your situation found that patients without initial improvement who increased from 15 mg to 30 mg showed:
- Significantly greater symptom reduction (p=0.003) 4
- Higher remission rates (34.7% vs 14.3%) 4
- However, increases beyond 30 mg showed no additional benefit 4
Timeline for Assessment
Wait 6-8 weeks at an adequate dose (15-30 mg) before declaring treatment failure 2. Guidelines emphasize:
- Early improvement (within 1-2 weeks) predicts final response 1, 5
- Maximum therapeutic effect occurs by 4-6 weeks 1
- If no ≥20% improvement by week 2 at 30 mg, consider switching strategies 4
Monitoring Requirements
Assess patient status within 1-2 weeks of dose changes for:
- Therapeutic response (mood, sleep, appetite)
- Adverse effects (sedation, weight gain, dizziness) 2
- Suicidal ideation (FDA black box warning for all antidepressants) 2
Common Pitfalls to Avoid
- Don't abandon mirtazapine prematurely: Partial improvement at 7.5 mg suggests potential responsiveness at therapeutic doses
- Don't exceed 30 mg without clear rationale: Evidence shows diminishing returns beyond 30 mg 4
- Don't forget mirtazapine's unique benefits: It promotes sleep, appetite, and has faster onset for anxiety symptoms compared to SSRIs 1, 6, 7
Expected Adverse Effects at Therapeutic Doses
- Most common: Sedation (dose at bedtime), increased appetite, weight gain 1, 8
- Advantages over SSRIs: No sexual dysfunction, no nausea, beneficial for insomnia 6, 7
- Weight gain averages only 1.4 kg over 40 weeks of continuation therapy 9
Duration of Treatment After Response
Once you achieve remission, continue treatment for:
- First episode: 4-9 months minimum 2, 10
- Recurrent depression: Consider longer-term maintenance (potentially years) 2, 10
Mirtazapine reduces relapse rates by >50% during continuation therapy (19.7% vs 43.8% placebo) 9.